S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Li Auto smashes estimates proving EVs can be profitable
Get ready for Christmas shopping-sprees with these 2 winners
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Li Auto smashes estimates proving EVs can be profitable
Get ready for Christmas shopping-sprees with these 2 winners
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Li Auto smashes estimates proving EVs can be profitable
Get ready for Christmas shopping-sprees with these 2 winners
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Li Auto smashes estimates proving EVs can be profitable
Get ready for Christmas shopping-sprees with these 2 winners

Confluent (CFLT) Stock Forecast & Price Target

$20.50
+1.79 (+9.57%)
(As of 11/28/2023 ET)
Compare
Today's Range
$19.06
$21.07
50-Day Range
$16.28
$31.50
52-Week Range
$14.69
$41.22
Volume
8.87 million shs
Average Volume
4.35 million shs
Market Capitalization
$6.31 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$29.67

Confluent Consensus Analyst Rating and Stock Price Forecast (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 26 Analyst Ratings

Analysts' Consensus Price Target

$29.67
44.72% Upside
High Forecast$42.00
Average Forecast$29.67
Low Forecast$21.00
TypeCurrent Forecast
11/29/22 to 11/29/23
1 Month Ago
10/30/22 to 10/30/23
3 Months Ago
8/31/22 to 8/31/23
1 Year Ago
11/29/21 to 11/29/22
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
19 Buy rating(s)
15 Buy rating(s)
13 Buy rating(s)
6 Buy rating(s)
Hold
6 Hold rating(s)
7 Hold rating(s)
6 Hold rating(s)
6 Hold rating(s)
Sell
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$29.67$36.68$36.58$35.36
Predicted Upside44.72% Upside29.58% Upside31.21% Upside17.69% Upside
Get Confluent Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CFLT and its competitors with MarketBeat's FREE daily newsletter.


CFLT Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CFLT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Confluent Stock vs. The Competition

TypeConfluentBusiness Services CompaniesS&P 500
Consensus Rating Score
2.69
2.59
2.49
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside44.72% Upside684.50% Upside2,838.33% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/28/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$34.00+81.72%
11/8/2023Capital One Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeEqual Weight ➝ Overweight$27.00+49.67%
11/6/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$22.00+23.94%
11/3/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$35.00 ➝ $24.00+38.97%
11/3/2023JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetMarket Outperform ➝ Market Outperform$41.00 ➝ $25.00+53.56%
11/3/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$42.00 ➝ $27.00+65.85%
11/3/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradePeer Perform ➝ Outperform$21.00+28.99%
11/3/2023Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$23.00+41.28%
11/2/2023Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$45.00 ➝ $23.00+41.28%
11/2/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$39.00 ➝ $26.00+59.71%
11/2/2023Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Hold$26.00+59.71%
11/2/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$40.00 ➝ $27.00+65.85%
11/2/2023Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$40.00 ➝ $30.00+84.28%
11/2/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underperform$38.00 ➝ $24.00-14.68%
9/28/2023William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform
8/2/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$36.00 ➝ $37.00+19.28%
6/21/2023DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$32.00 ➝ $42.00+24.56%
6/15/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$27.00 ➝ $38.00+12.13%
6/14/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$20.00 ➝ $31.00-16.53%
6/14/2023Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$28.00 ➝ $40.00+7.70%
6/14/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$24.00 ➝ $39.00+5.01%
6/14/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$35.00 ➝ $41.00+10.39%
5/4/2023VNET Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
3/6/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform$31.00+19.88%
2/13/2023Moffett Nathanson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$36.00+42.86%
1/31/2023Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$35.00 ➝ $30.00+30.26%
1/17/2023FBN Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$30.00+46.99%
1/6/2023Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeSector Outperform ➝ Sector Perform$21.00+17.15%
(Data available from 11/29/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












CFLT Price Target - Frequently Asked Questions

What is Confluent's consensus rating and price target?

According to the issued ratings of 26 analysts in the last year, the consensus rating for Confluent stock is Moderate Buy based on the current 1 sell rating, 6 hold ratings and 19 buy ratings for CFLT. The average twelve-month price prediction for Confluent is $29.67 with a high price target of $42.00 and a low price target of $21.00. Learn more on CFLT's analyst rating history.

Do Wall Street analysts like Confluent more than its competitors?

Analysts like Confluent more than other Business Services companies. The consensus rating score for Confluent is 2.69 while the average consensus rating score for business services companies is 2.59. Learn more on how CFLT compares to other companies.

Is Confluent being upgraded or downgraded by Wall Street analysts?

Over the previous 90 days, Confluent's stock had 3 upgrades and 2 downgrades by analysts.

Does Confluent's stock price have much upside?

According to analysts, Confluent's stock has a predicted upside of 35.95% based on their 12-month stock forecasts.


Stock Ratings Reports and Tools

This page (NASDAQ:CFLT) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -